查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607750

定量吸入器的全球市场:产品·推进器·技术·适应症·流通管道·不同地区的预测 (～2032年)

Global Metered Dose Inhalers Market Research Report Information By Product, By Propellant Type, By Technology, By Indication, By Distribution Channel And By Region Forecast Till 2032
出版日期: | 出版商: Market Research Future | 英文 151 Pages | 订单完成后即时交付

价格

2023 年和 2024 年全球计量吸入器市场规模预计为 158 亿美元 6 预测期间同期，2019 年为171 亿美元。预计复合年增长率为 43%，到 2032 年将达到 300 亿美元。由于呼吸系统疾病盛行率的增加、新产品的推出以及公众意识和教育的提高，全球计量吸入器市场正在成长。

由于新产品的可用性不断扩大，全球计量吸入器市场正在经历显着成长。这些产品的推出带来的技术进步，例如改进的给药系统和人体工学设计，符合患者对易用性和用药依从性的需求。创新的配方和组合为多种呼吸系统疾病提供了新的治疗选择，提高了治疗效果和患者治疗结果的品质。

区域展望

北美预计将在 2023 年拥有最大的市场占有率，而亚太地区预计在预测期内呈现最高的复合年增长率。 北美计量吸入器市场的特点是支持性的监管环境、技术进步和不断增长的医疗保健要求，所有这些都推动了强劲的成长。此外，尖端计量吸入器的发展推动了该区域市场的发展，而这得益于对研发和先进医疗基础设施的大量投资。

欧洲计量吸入器市场的特点是医疗基础设施完善和医疗支出不断增长。

在预测期内，亚太地区预计将在多种因素的推动下实现强劲发展。预计它也将成为成长最快的地区。中国、印度和日本等国家医疗保健基础设施的快速扩张和医疗保健基础设施投资的增加推动了对先进吸入器的需求。

本报告提供全球定量吸入器的市场调查，市场定义和概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·地区/各主要国家的明细，竞争环境，主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 进入者增加产品发布
    • 提高意识和教育
  • 阻碍因素
    • 城市进入者自愿召回产品
    • 强有力的监管政策
  • 机会
    • 私人和公共机构增加投资
    • 计量吸入器的进展正在进行临床试验

第5章 市场要素分析

  • 波特的五力分析
  • COVID-19对全球定量吸入器市场带来的影响
  • 全球定量吸入器市场主要趋势

第6章 全球定量吸入器市场:各产品

  • 概要
  • 发表会式
  • 呼吸工作式

第7章 按全球定量吸入器市场:推进器

  • 概要
  • HFA 134A
  • HFA 227EA
  • HFA 152A

第8章 全球定量吸入器市场:各技术

  • 概要
  • 肺平台技术
  • 鼻腔平台技术

第9章 全球定量吸入器市场:各适应症

  • 概要
  • 气喘
  • 慢性阻塞性肺病
  • 其他

第10章 全球定量吸入器市场:各流通管道

  • 概要
  • 医院药局
  • 零售药局
  • 线上药局

第11章 全球定量吸入器市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他
  • 其他地区
    • 中东·非洲
    • 南美

第12章 竞争情形

  • 市场占有率分析
  • 竞争仪表板
  • 上市公司的股票概要
  • 比较分析:主要企业的财务
  • 主要的展开·成长策略

第13章 企业简介

  • ASTRAZENECA
  • GSK PLC
  • ORGANON GROUP OF COMPANIES
  • CIPLA INC.
  • LUPIN PHARMACEUTICALS, INC.
  • ZYDUS GROUP
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • VIATRIS INC.
  • ARISTOPHARMA LTD.
  • BEXIMCO PHARMACEUTICALS LTD.
Product Code: MRFR/HC/26937-CR

Global Metered Dose Inhalers Market Research Report Information By Product (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By Propellant Type (HFA 134A, HFA 227EA, HFA 152A), By Technology (Pulmonary Platform Technologies, Nasal Platform Technologies), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Forecast Till 2032

Market Overview

In 2023, the Metered Dose Inhalers Market was estimated to be worth USD 15.8 billion. Over the forecast period (2024-2032), the industry is anticipated to expand from USD 17.1 billion in 2024 to USD 30.0 billion by 2032, with a compound annual growth rate (CAGR) of 6.43%. The global metered-dose inhaler market is experiencing development due to the increasing prevalence of respiratory diseases, the launch of new products by market players, and the increasing awareness and education of the public.

The global MDI market is experiencing significant growth due to the increasing availability of new metered dose inhaler (MDI) products. The technological advancements that these launches bring about, such as improved drug delivery systems and ergonomic designs, are tailored to the preferences of patients for simplicity of use and adherence. Innovative formulations and combinations provide additional therapeutic options for a diverse array of respiratory conditions, thereby enhancing the efficacy of treatment and the quality of patient outcomes.

Market segment insights

The Metered Dose Inhalers Market has been segmented into Press Metered Dose Inhalers and Breath actuated Metered Dose Inhalers based on product.

The Metered Dose Inhalers Market has been segmented into HFA 134a, HFA 227ea, and HFA-152a based on propellant type.

The Metered Dose Inhalers Market has been segmented into pulmonary platform technologies and nasal platform technologies based on technology.

Metered Dose Inhalers Market has been segmented into Asthma, COPD, and other categories based on indication.

Hospital pharmacies, retail pharmacies, and online pharmacies comprise the Metered Dose Inhalers Market, contingent upon their distribution channels.

Regional Perspectives

In 2023, the market share that North America possessed was the most significant. Nevertheless, Asia-Pacific is anticipated to experience the most significant compound annual growth rate (CAGR) during the 2024-2032 forecast period.

The Metered Dose Inhalers market in North America is distinguished by a supportive regulatory environment, technological advancements, and increased healthcare requirements, all of which are driving robust growth. Additionally, the market is driven by the development of state-of-the-art Metered Dose Inhalers, which is made possible by a substantial investment in research and development and a sophisticated healthcare infrastructure.

Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, follows the Americas region. The Metered Dose Inhalers market in Europe is characterized by a well-established healthcare infrastructure and an increase in healthcare expenditure.

Over the forecast period, the Asia-Pacific region is anticipated to experience robust development, which is driven by a variety of key factors. It is also projected to be the fastest-growing region. The demand for sophisticated inhalers is being driven by the rapid expansion of healthcare infrastructure and the increasing investments in healthcare infrastructure in countries such as China, India, and Japan.

Major Players

AstraZeneca (UK), GSK PLC. (UK), Organon (US), Cipla, Inc. (India), Lupin Pharmaceuticals, Inc. (India), Zydus Group (India), Teva Pharmaceutical Industries Ltd. (Israel), Viatris Inc. (US), Aristopharma Ltd. (Bangladesh), and Beximco Pharmaceuticals Limited (Bangladesh) are among the key companies in the Metered Dose Inhalers Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PRODUCT LAUNCH BY MARKET PLAYERS
    • 4.2.2 GROWING AWARENESS AND EDUCATION
  • 4.3 RESTRAINTS
    • 4.3.1 VOLUNTARY PRODUCT RECALL FROM MARKET PLAYERS
    • 4.3.2 STRINGENT REGULATORY POLICIES
  • 4.4 OPPORTUNITY
    • 4.4.1 INCREASING INVESTMENT BY PRIVATE AND PUBLIC ORGANIZATION
    • 4.4.2 ONGOING CLINICAL TRIALS ASSOCIATED WITH METERED DOSE INHALER

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL METERED DOSE INHALERS MARKET
  • 5.3 KEY TRENDS FOR GLOBAL METERED DOSE INHALERS MARKET

6 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 PRESS METERED DOSE INHALERS
  • 6.3 BREATH ACTUATED METERED DOSE INHALERS

7 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE

  • 7.1 OVERVIEW
  • 7.2 HFA 134A
  • 7.3 HFA 227EA
  • 7.4 HFA-152A

8 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY

  • 8.1 OVERVIEW
  • 8.2 PULMONARY PLATFORM TECHNOLOGIES
  • 8.3 NASAL PLATFORM TECHNOLOGIES

9 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION

  • 9.1 OVERVIEW
  • 9.2 ASTHMA
  • 9.3 COPD
  • 9.4 OTHERS

10 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL

  • 10.1 OVERVIEW
  • 10.2 HOSPITAL PHARMACIES
  • 10.3 RETAIL PHARMACIES
  • 10.4 ONLINE PHARMACIES

11 GLOBAL METERED DOSE INHALER MARKET, BY REGION

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 US
    • 11.2.2 CANADA
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 INDIA
    • 11.4.3 JAPAN
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 REST OF ASIA-PACIFIC
  • 11.5 REST OF THE WORLD
    • 11.5.1 MIDDLE EAST & AFRICA
    • 11.5.2 SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET SHARE ANALYSIS,
  • 12.3 COMPETITOR DASHBOARD
  • 12.4 PUBLIC PLAYERS STOCK SUMMARY
  • 12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1 PARTNERSHIP
    • 12.6.2 PRODUCT LAUNCH/PRODUCT APPROVAL

13 COMPANY PROFILES

  • 13.1 ASTRAZENECA
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL OVERVIEW
    • 13.1.3 PRODUCTS OFFERED
    • 13.1.4 KEY DEVELOPMENTS
    • 13.1.5 SWOT ANALYSIS
    • 13.1.6 KEY STRATEGIES
  • 13.2 GSK PLC
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL OVERVIEW
    • 13.2.3 PRODUCT OFFERED
    • 13.2.4 KEY DEVELOPMENTS
    • 13.2.5 SWOT ANALYSIS
    • 13.2.6 KEY STRATEGIES
  • 13.3 ORGANON GROUP OF COMPANIES
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL OVERVIEW
    • 13.3.3 PRODUCTS OFFERED
    • 13.3.4 KEY DEVELOPMENTS
    • 13.3.5 KEY STRATEGIES
  • 13.4 CIPLA INC.
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL OVERVIEW
    • 13.4.3 PRODUCTS OFFERED
    • 13.4.4 KEY DEVELOPMENTS
    • 13.4.5 SWOT ANALYSIS
    • 13.4.6 KEY STRATEGIES
  • 13.5 LUPIN PHARMACEUTICALS, INC.
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL OVERVIEW
    • 13.5.3 PRODUCT OFFERED
    • 13.5.4 KEY DEVELOPMENTS
    • 13.5.5 SWOT ANALYSIS
    • 13.5.6 KEY STRATEGIES
  • 13.6 ZYDUS GROUP
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL OVERVIEW
    • 13.6.3 PRODUCTS OFFERED
    • 13.6.4 KEY DEVELOPMENTS
    • 13.6.5 KEY STRATEGIES
  • 13.7 TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL OVERVIEW
    • 13.7.3 PRODUCTS OFFERED
    • 13.7.4 KEY DEVELOPMENTS
    • 13.7.5 SWOT ANALYSIS
    • 13.7.6 KEY STRATEGIES
  • 13.8 VIATRIS INC.
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 FINANCIAL OVERVIEW
    • 13.8.3 PRODUCTS OFFERED
    • 13.8.4 KEY DEVELOPMENTS
    • 13.8.5 SWOT ANALYSIS
    • 13.8.6 KEY STRATEGIES
  • 13.9 ARISTOPHARMA LTD.
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL OVERVIEW
    • 13.9.3 PRODUCT OFFERED
    • 13.9.4 KEY DEVELOPMENTS

SOURCE: ANNUAL REPORT AND PRESS RELEASES

    • 13.9.5 KEY STRATEGIES
  • 13.10 BEXIMCO PHARMACEUTICALS LTD.
    • 13.10.1 COMPANY OVERVIEW
    • 13.10.2 FINANCIAL OVERVIEW
    • 13.10.3 PRODUCTS OFFERED
    • 13.10.4 KEY DEVELOPMENTS
    • 13.10.5 KEY STRATEGIES
  • 13.11 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 4 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (UNITS)
  • TABLE 6 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (UNITS)
  • TABLE 8 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019-2032 (UNITS)
  • TABLE 10 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (UNITS)
  • TABLE 12 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (UNITS)
  • TABLE 14 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (UNITS)
  • TABLE 16 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 18 GLOBAL METERED DOSE INHALERS MARKET, FOR PULMONARY PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL METERED DOSE INHALERS MARKET, FOR PULMONARY PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (UNITS)
  • TABLE 20 GLOBAL METERED DOSE INHALERS MARKET, FOR NASAL PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL METERED DOSE INHALERS MARKET, FOR NASAL PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (UNITS)
  • TABLE 22 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL METERED DOSE INHALERS MARKET, FOR ASTHMA, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 GLOBAL METERED DOSE INHALERS MARKET, FOR COPD, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 25 GLOBAL METERED DOSE INHALERS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 26 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 27 GLOBAL METERED DOSE INHALERS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 28 GLOBAL METERED DOSE INHALERS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 29 GLOBAL METERED DOSE INHALERS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 30 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 31 NORTH AMERICA: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 32 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 33 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 34 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 35 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 36 NORTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 37 NORTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 38 NORTH AMERICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 39 NORTH AMERICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 40 US: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 41 US: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 42 US: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 43 US: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 44 US: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 45 US: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 46 US: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 47 US: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 48 US: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 49 CANADA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 50 CANADA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 51 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 52 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 53 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 54 CANADA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 55 CANADA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 56 CANADA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 57 CANADA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 58 EUROPE: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 59 EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 60 EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 61 EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 62 EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 63 EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 64 EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 65 EUROPE: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 66 EUROPE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 67 GERMANY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 68 GERMANY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 69 GERMANY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 70 GERMANY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 71 GERMANY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 72 GERMANY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 73 GERMANY: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 74 GERMANY: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 75 FRANCE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 76 FRANCE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 77 FRANCE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 78 FRANCE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 79 FRANCE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 80 FRANCE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 81 FRANCE: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 82 FRANCE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 83 UK: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 84 UK: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 85 UK: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 86 UK: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 87 UK: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 88 UK: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 89 UK: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 90 UK: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 91 ITALY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 92 ITALY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 93 ITALY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 94 ITALY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 95 ITALY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 96 ITALY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 97 ITALY: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 98 ITALY: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 99 SPAIN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 100 SPAIN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 101 SPAIN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 102 SPAIN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 103 SPAIN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 104 SPAIN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 105 SPAIN: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 106 SPAIN: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 107 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 108 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 109 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 110 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 111 REST OF EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 112 REST OF EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 113 REST OF EUROPE: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 114 REST OF EUROPE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 115 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 116 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 117 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 118 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 119 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 120 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 121 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 122 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 123 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 124 CHINA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 125 CHINA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 126 CHINA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 127 CHINA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 128 CHINA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 129 CHINA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 130 CHINA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 131 CHINA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 132 INDIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 133 INDIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 134 INDIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 135 INDIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 136 INDIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 137 INDIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 138 INDIA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 139 INDIA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 140 JAPAN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 141 JAPAN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 142 JAPAN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 143 JAPAN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 144 JAPAN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 145 JAPAN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 146 JAPAN: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 147 JAPAN: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 148 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 149 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 150 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 151 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 152 SOUTH KOREA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 153 SOUTH KOREA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 154 SOUTH KOREA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 155 SOUTH KOREA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 156 AUSTRALIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 157 AUSTRALIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 158 AUSTRALIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 159 AUSTRALIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 160 AUSTRALIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 161 AUSTRALIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 162 AUSTRALIA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 163 AUSTRALIA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 164 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 165 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 166 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 167 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 168 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 169 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 170 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 171 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 172 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 173 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 174 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 175 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 176 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 177 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 178 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 179 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 180 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 183 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 184 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 185 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 186 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 187 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 188 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 189 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 190 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 191 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 192 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 193 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 194 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 195 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 196 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 197 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 198 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 199 PARTNERSHIP
  • TABLE 200 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 201 ASTRAZENECA: PRODUCT OFFERED
  • TABLE 202 ASTRAZENECA: KEY DEVELOPMENTS
  • TABLE 203 GSK PLC: PRODUCTS OFFERED
  • TABLE 204 ORGANON GROUP OF COMPANIES: PRODUCT OFFERED
  • TABLE 205 CIPLA INC.: PRODUCT OFFERED
  • TABLE 206 CIPLA INC.: KEY DEVELOPMENTS
  • TABLE 207 LUPIN PHARMACEUTICALS, INC.: PRODUCTS OFFERED
  • TABLE 208 LUPIN PHARMACEUTICALS, INC.: KEY DEVELOPMENTS
  • TABLE 209 ZYDUS GROUP: PRODUCTS OFFERED
  • TABLE 210 ZYDUS GROUP: KEY DEVELOPMENTS
  • TABLE 211 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED
  • TABLE 212 VIATRIS INC.: PRODUCTS OFFERED
  • TABLE 213 ARISTOPHARMA LTD.: PRODUCTS OFFERED
  • TABLE 214 BEXIMCO PHARMACEUTICALS LTD.: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL METERED DOSE INHALER MARKET: STRUCTURE
  • FIGURE 2 GLOBAL METERED DOSE INHALERS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL METERED DOSE INHALERS MARKET
  • FIGURE 6 GLOBAL METERED DOSE INHALERS MARKET, PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 7 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY PRODUCT,
  • FIGURE 9 GLOBAL METERED DOSE INHALERS MARKET, PROPELLANT TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY PROPELLANT TYPE,
  • FIGURE 12 GLOBAL METERED DOSE INHALERS MARKET, TECHNOLOGY, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY TECHNOLOGY,
  • FIGURE 15 GLOBAL METERED DOSE INHALERS MARKET, INDICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY INDICATION,
  • FIGURE 18 GLOBAL METERED DOSE INHALERS MARKET, DISTRIBUTION CHANNEL, 2023 & 2032 (USD MILLION)
  • FIGURE 19 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2023 & 2032 (USD MILLION)
  • FIGURE 20 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY DISTRIBUTION CHANNEL,
  • FIGURE 21 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 22 GLOBAL METERED DOSE INHALER MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 23 NORTH AMERICA MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 NORTH AMERICA METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 NORTH AMERICA METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 EUROPE MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 EUROPE METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 EUROPE METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 31 ASIA-PACIFIC METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 33 REST OF THE WORLD METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 34 REST OF THE WORLD METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 35 GLOBAL METERED DOSE INHALER MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 36 COMPETITOR DASHBOARD: GLOBAL METERED DOSE INHALER MARKET
  • FIGURE 37 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 ASTRAZENECA: SWOT ANALYSIS
  • FIGURE 39 GSK PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 GSK PLC: SWOT ANALYSIS
  • FIGURE 41 ORGANON GROUP OF COMPANIES: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 42 CIPLA INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 CIPLA INC.: SWOT ANALYSIS
  • FIGURE 44 LUPIN PHARMACEUTICALS, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 LUPIN PHARMACEUTICALS, INC.: SWOT ANALYSIS
  • FIGURE 46 ZYDUS GROUP: FINANCIAL OVERVIEW
  • FIGURE 47 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
  • FIGURE 49 VIATRIS INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 50 VIATRIS INC.: SWOT ANALYSIS
  • FIGURE 51 BEXIMCO PHARMACEUTICALS LTD.: FINANCIAL OVERVIEW SNAPSHOT